tm
Seeing Is Believing
tm
Seeing Is Believing
TBPH is currently covered by 4 analysts with an average potential upside of $8.1 (51.19%) backed by displayed 44 price targets and 68 ratings.
Analysts average stock forecasts to be materialized ratio is 33.94% with an average time for these price targets to be met of 88.83 days.
Highest price target for TBPH is 10, Lowest price target is 9, average price target is 9.5.
Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 08-Aug-2023. First documented stock forecast 03-Feb-2015.
Currently, out of the existing stock ratings of TBPH - 3 which are a Sell (37.5%), 4 which are a Buy (50%), 1 which are a Hold (12.5%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
20
$10.94 (120.75%)
20
3 months 23 days ago
3/10 (30%)
$6.1 (47.79%)
35
Buy
14
$4.94 (54.53%)
12
1 years 14 days ago
1/3 (33.33%)
$2.02 (19.98%)
20
Sell
10
$-0.48 (-4.58%)
1 years 4 months 6 days ago
2/8 (25%)
$7.96 (53.31%)
70
Buy
12
$1.52 (14.50%)
1 years 6 months 8 days ago
5/9 (55.56%)
$7.59 (39.91%)
54
Hold
18
1 years 6 months 25 days ago
0/1 (0%)
$8.76 (94.81%)
What is TBPH (Theravance Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on TBPH (Theravance Biopharma) with a proven track record?
Which analyst has the most public recommendations on TBPH (Theravance Biopharma)?
Which analyst is the currently most bullish on TBPH (Theravance Biopharma)?
Which analyst is the currently most reserved on TBPH (Theravance Biopharma)?
